AIMMS Seminar: Prof. Michael Ramsey
16.00 - 17.00h
O|2 building, room 01W08
AIMMS Seminar: Micro- and Nanofluidic Technologies for Addressing Biochemical Measurements
Prof. Michael Ramsey (Centers of Genome Science and Biomedical Microtechnologies, University of North Carolina)
Amsterdam Institute for Molecules, Medicines and Systems
Prof. Michael Ramsey (Centers of Genome Science and Biomedical Microtechnologies, University of North Carolina) will provide an AIMMS Seminar on 30 March entitled 'Micro- and Nanofluidic Technologies for Addressing Biochemical Measurements'.
You are all cordially invited (drinks afterwards)!
The first report of micromachined devices that emulate the functions of laboratory chemical instrumentation, i.e., the silicon gas chromatograph (GC) occurred nearly four decades ago. Due largely to the modest performance of these early devices, further developments in microelectromechanical systems (MEMS) based chemical instrumentation were slow to materialize. Microfabricated fluidic devices that accomplished chemical measurement strategies were first reported in the early 1990s and demonstrated significant advantages over conventional approaches. Since that time there has been rapidly growing interest in microfabricated fluidic devices (microfluidic chips). The diversity of chemical and biochemical measurement techniques that have been implemented on micro- or nanofabricated devices is large, in the research literature and as commercial products. Current activities in our laboratory fall into four categories; microfluidic chemical separations with integrated nano-electrospray, microfluidic point-of-care diagnostic applications, nanofluidic devices for single molecule DNA characterization, and MEMS-based mass spectrometry components that enable the realization of handheld mass spectrometers. Selected topics will be presented.
Prof. Michael Ramsey holds the Minnie N. Goldby Distinguished Professor of Chemistry Chair at the University of North Carolina - Chapel Hill. In addition, he is a member of the faculty in the Departments of Biomedical Engineering and Applied Physical Sciences, and the Carolina Center for Genome Sciences. He is a member of the National Academy of Engineering and a Fellow of the Optical Society of America, the American Chemical Society, and the American Institute for Medical and Biological Engineering. Ramsey is the scientific founder of Caliper Technologies (NASDAQ:CALP), renamed Caliper Life Sciences and acquired by PerkinElmer in 2011. He is also the scientific founder of the venture backed companies 908 Devices Inc., a company developing revolutionary compact mass spectrometry and separations-based products, and Genturi Inc., a genomics tools provider. He has published over 300 peer-reviewed papers and presented over 500 invited, plenary, or named lectures. In addition, he has over 100 issued patents.